These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31496901)

  • 1.
    Hassan H; Razak HRA; Saad FFA; Kumar V
    Malays J Med Sci; 2019 Jul; 26(4):122-126. PubMed ID: 31496901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bench-to-Bedside Theranostics in Nuclear Medicine.
    Jokar N; Assadi M; Yordanova A; Ahmadzadehfar H
    Curr Pharm Des; 2020; 26(31):3804-3811. PubMed ID: 32067609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted scintigraphy and radionuclide therapy.
    Bernard BF; Krenning E; Breeman WA; Visser TJ; Bakker WH; Srinivasan A; de Jong M
    Nucl Med Commun; 2000 Nov; 21(11):1079-85. PubMed ID: 11192715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amount.
    de Jong M; Breeman WA; Bernard BF; van Gameren A; de Bruin E; Bakker WH; van der Pluijm ME; Visser TJ; Mäcke HR; Krenning EP
    Eur J Nucl Med; 1999 Jul; 26(7):693-8. PubMed ID: 10398816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide radiopharmaceuticals for diagnosis and therapy.
    Signore A; Annovazzi A; Chianelli M; Corsetti F; Van de Wiele C; Watherhouse RN
    Eur J Nucl Med; 2001 Oct; 28(10):1555-65. PubMed ID: 11685500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated preparation of 2-[
    Haskali MB; Roselt PD; Hicks RJ; Hutton CA
    J Labelled Comp Radiopharm; 2018 Feb; 61(2):61-67. PubMed ID: 29143364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of labelling methods on biodistribution and imaging properties of radiolabelled peptides for visualisation of molecular therapeutic targets.
    Tolmachev V; Orlova A
    Curr Med Chem; 2010; 17(24):2636-55. PubMed ID: 20491631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated GMP compliant production of [
    Tshibangu T; Cawthorne C; Serdons K; Pauwels E; Gsell W; Bormans G; Deroose CM; Cleeren F
    EJNMMI Radiopharm Chem; 2020 Jan; 5(1):4. PubMed ID: 31997090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiolabeled peptides in oncology: role in diagnosis and treatment.
    Weiner RE; Thakur ML
    BioDrugs; 2005; 19(3):145-63. PubMed ID: 15984900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002.
    de Jong M; Kwekkeboom D; Valkema R; Krenning EP
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):463-9. PubMed ID: 12569416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for the use of radiolabelled peptides in diagnosis and therapy.
    Koopmans KP; Glaudemans AW
    Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S4-10. PubMed ID: 22388630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The aluminium-[
    Archibald SJ; Allott L
    EJNMMI Radiopharm Chem; 2021 Aug; 6(1):30. PubMed ID: 34436693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy.
    van Hagen PM; Breeman WA; Bernard HF; Schaar M; Mooij CM; Srinivasan A; Schmidt MA; Krenning EP; de Jong M
    Int J Cancer; 2000 Aug; 90(4):186-98. PubMed ID: 10993959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomedical applications of radioiodinated peptides.
    Oliveira MC; Correia JDG
    Eur J Med Chem; 2019 Oct; 179():56-77. PubMed ID: 31238251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of [
    Wang M; Zhang H; Wang H; Feng H; Deng H; Wu Z; Lu H; Li Z
    Mol Pharm; 2018 Aug; 15(8):3093-3100. PubMed ID: 29889537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer imaging with radiolabelled peptide from complementarity-determining region of antitumour antibody.
    Sivolapenko GB; Douli V; Pectasides D; Skarlos D; Sirmalis G; Hussain R; Cook J; Courtenay-Luck NS; Merkouri E; Konstantinides K
    Lancet; 1995 Dec 23-30; 346(8991-8992):1662-6. PubMed ID: 8551823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methoxinine - an alternative stable amino acid substitute for oxidation-sensitive methionine in radiolabelled peptide conjugates.
    Grob NM; Behe M; von Guggenberg E; Schibli R; Mindt TL
    J Pept Sci; 2017 Jan; 23(1):38-44. PubMed ID: 28054429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma Emitters in Pancreatic Endocrine Tumors Imaging in the PET Era: Is there a Clinical Space for 99mTc-peptides?
    Briganti V; Cuccurullo V; Di Stasio GD; Mansi L
    Curr Radiopharm; 2019; 12(2):156-170. PubMed ID: 30827276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabelled regulatory peptides for imaging and therapy.
    Breeman WA; Kwekkeboom DJ; de Blois E; de Jong M; Visser TJ; Krenning EP
    Anticancer Agents Med Chem; 2007 May; 7(3):345-57. PubMed ID: 17504160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
    Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
    Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.